Metformin increases liver accumulation of vitamin B12-An experimental study in rats

E. Greibe, J. W. Miller, S. H. Foutouhi, Ralph Green, E. Nexo

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Aims/hypothesis: Patients treated with metformin exhibit low levels of plasma vitamin B12 (B12), and are considered at risk for developing B12 deficiency. In this study, we investigated the effect of metformin treatment on B12 uptake and distribution in rats. Methods: Sprague Dawley rats (n = 18) were divided into two groups and given daily subcutaneous injections with metformin or saline (control) for three weeks. Following this, the animals received an oral dose of radio-labeled B 12 (57[Co]-B12), and urine and feces were collected for 24 h. Plasma, bowel content, liver, and kidneys were collected and analyzed for B12, unsaturated B12-binding capacity, and 57[Co]-B12. Results: Three weeks of metformin treatment reduced plasma B12 by 22% or 289 [47-383] pmol/L (median and [range]) (p = 0.001), while no effect was observed on unsaturated B12-binding capacity. Compared with controls, the amount of B12 in the liver was 36% (p = 0.007) higher in metformin-treated rats, while the B12 content in the kidney was 34% (p = 0.013) lower. No difference in the total amount of absorbed 57[Co]-B12 present in the tissues and organs studied was found, suggesting that metformin has no decreasing effect on the B12 absorption. Conclusions/interpretation: These results show that metformin treatment increases liver accumulation of B12, thereby resulting in decreases in circulating B12 and kidney accumulation of the vitamin. Our data questions whether the low plasma B12 observed in patients treated with metformin reflects impaired B12 status, and rather suggests altered tissue distribution and metabolism of the vitamin.

Original languageEnglish (US)
Pages (from-to)1062-1065
Number of pages4
JournalBiochimie
Volume95
Issue number5
DOIs
StatePublished - May 2013

Fingerprint

Metformin
Vitamin B 12
Liver
Rats
Plasmas
Kidney
Vitamins
Tissue
Tissue Distribution
Subcutaneous Injections
Radio
Metabolism
Feces
Sprague Dawley Rats
Animals
Therapeutics
Urine

Keywords

  • Absorption
  • Metformin
  • Rat model
  • Tissue distribution
  • Vitamin B

ASJC Scopus subject areas

  • Biochemistry

Cite this

Metformin increases liver accumulation of vitamin B12-An experimental study in rats. / Greibe, E.; Miller, J. W.; Foutouhi, S. H.; Green, Ralph; Nexo, E.

In: Biochimie, Vol. 95, No. 5, 05.2013, p. 1062-1065.

Research output: Contribution to journalArticle

Greibe, E. ; Miller, J. W. ; Foutouhi, S. H. ; Green, Ralph ; Nexo, E. / Metformin increases liver accumulation of vitamin B12-An experimental study in rats. In: Biochimie. 2013 ; Vol. 95, No. 5. pp. 1062-1065.
@article{b1e1bfe7fca148988c87e1b87dc46368,
title = "Metformin increases liver accumulation of vitamin B12-An experimental study in rats",
abstract = "Aims/hypothesis: Patients treated with metformin exhibit low levels of plasma vitamin B12 (B12), and are considered at risk for developing B12 deficiency. In this study, we investigated the effect of metformin treatment on B12 uptake and distribution in rats. Methods: Sprague Dawley rats (n = 18) were divided into two groups and given daily subcutaneous injections with metformin or saline (control) for three weeks. Following this, the animals received an oral dose of radio-labeled B 12 (57[Co]-B12), and urine and feces were collected for 24 h. Plasma, bowel content, liver, and kidneys were collected and analyzed for B12, unsaturated B12-binding capacity, and 57[Co]-B12. Results: Three weeks of metformin treatment reduced plasma B12 by 22{\%} or 289 [47-383] pmol/L (median and [range]) (p = 0.001), while no effect was observed on unsaturated B12-binding capacity. Compared with controls, the amount of B12 in the liver was 36{\%} (p = 0.007) higher in metformin-treated rats, while the B12 content in the kidney was 34{\%} (p = 0.013) lower. No difference in the total amount of absorbed 57[Co]-B12 present in the tissues and organs studied was found, suggesting that metformin has no decreasing effect on the B12 absorption. Conclusions/interpretation: These results show that metformin treatment increases liver accumulation of B12, thereby resulting in decreases in circulating B12 and kidney accumulation of the vitamin. Our data questions whether the low plasma B12 observed in patients treated with metformin reflects impaired B12 status, and rather suggests altered tissue distribution and metabolism of the vitamin.",
keywords = "Absorption, Metformin, Rat model, Tissue distribution, Vitamin B",
author = "E. Greibe and Miller, {J. W.} and Foutouhi, {S. H.} and Ralph Green and E. Nexo",
year = "2013",
month = "5",
doi = "10.1016/j.biochi.2013.02.002",
language = "English (US)",
volume = "95",
pages = "1062--1065",
journal = "Biochimie",
issn = "0300-9084",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Metformin increases liver accumulation of vitamin B12-An experimental study in rats

AU - Greibe, E.

AU - Miller, J. W.

AU - Foutouhi, S. H.

AU - Green, Ralph

AU - Nexo, E.

PY - 2013/5

Y1 - 2013/5

N2 - Aims/hypothesis: Patients treated with metformin exhibit low levels of plasma vitamin B12 (B12), and are considered at risk for developing B12 deficiency. In this study, we investigated the effect of metformin treatment on B12 uptake and distribution in rats. Methods: Sprague Dawley rats (n = 18) were divided into two groups and given daily subcutaneous injections with metformin or saline (control) for three weeks. Following this, the animals received an oral dose of radio-labeled B 12 (57[Co]-B12), and urine and feces were collected for 24 h. Plasma, bowel content, liver, and kidneys were collected and analyzed for B12, unsaturated B12-binding capacity, and 57[Co]-B12. Results: Three weeks of metformin treatment reduced plasma B12 by 22% or 289 [47-383] pmol/L (median and [range]) (p = 0.001), while no effect was observed on unsaturated B12-binding capacity. Compared with controls, the amount of B12 in the liver was 36% (p = 0.007) higher in metformin-treated rats, while the B12 content in the kidney was 34% (p = 0.013) lower. No difference in the total amount of absorbed 57[Co]-B12 present in the tissues and organs studied was found, suggesting that metformin has no decreasing effect on the B12 absorption. Conclusions/interpretation: These results show that metformin treatment increases liver accumulation of B12, thereby resulting in decreases in circulating B12 and kidney accumulation of the vitamin. Our data questions whether the low plasma B12 observed in patients treated with metformin reflects impaired B12 status, and rather suggests altered tissue distribution and metabolism of the vitamin.

AB - Aims/hypothesis: Patients treated with metformin exhibit low levels of plasma vitamin B12 (B12), and are considered at risk for developing B12 deficiency. In this study, we investigated the effect of metformin treatment on B12 uptake and distribution in rats. Methods: Sprague Dawley rats (n = 18) were divided into two groups and given daily subcutaneous injections with metformin or saline (control) for three weeks. Following this, the animals received an oral dose of radio-labeled B 12 (57[Co]-B12), and urine and feces were collected for 24 h. Plasma, bowel content, liver, and kidneys were collected and analyzed for B12, unsaturated B12-binding capacity, and 57[Co]-B12. Results: Three weeks of metformin treatment reduced plasma B12 by 22% or 289 [47-383] pmol/L (median and [range]) (p = 0.001), while no effect was observed on unsaturated B12-binding capacity. Compared with controls, the amount of B12 in the liver was 36% (p = 0.007) higher in metformin-treated rats, while the B12 content in the kidney was 34% (p = 0.013) lower. No difference in the total amount of absorbed 57[Co]-B12 present in the tissues and organs studied was found, suggesting that metformin has no decreasing effect on the B12 absorption. Conclusions/interpretation: These results show that metformin treatment increases liver accumulation of B12, thereby resulting in decreases in circulating B12 and kidney accumulation of the vitamin. Our data questions whether the low plasma B12 observed in patients treated with metformin reflects impaired B12 status, and rather suggests altered tissue distribution and metabolism of the vitamin.

KW - Absorption

KW - Metformin

KW - Rat model

KW - Tissue distribution

KW - Vitamin B

UR - http://www.scopus.com/inward/record.url?scp=84875820273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875820273&partnerID=8YFLogxK

U2 - 10.1016/j.biochi.2013.02.002

DO - 10.1016/j.biochi.2013.02.002

M3 - Article

C2 - 23402786

AN - SCOPUS:84875820273

VL - 95

SP - 1062

EP - 1065

JO - Biochimie

JF - Biochimie

SN - 0300-9084

IS - 5

ER -